Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Trevi Therapeutics Announces Election of James V. Cassella, Ph.D. to Board of Directors | ||
By: GlobeNewswire - 18 Feb 2020 | Back to overview list |
|
Seasoned biopharmaceutical executive with over 30 years of drug development experience NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced the election of James V. Cassella, Ph.D. to Trevi’s Board of Directors. Dr. Cassella joins Trevi’s Board with over 30 years of drug development experience working with emerging growth biopharmaceutical companies. He has served as Chief Development Officer of Concert Pharmaceuticals since 2015, and prior to that held senior executive and leadership roles with Alexza Pharmaceuticals, Inc. and Neurogen Corporation. Before joining the biopharmaceutical industry, Dr. Cassella was Assistant Professor of Neurosciences at Oberlin College. Dr. Cassella received his Ph.D. in Physiological Psychology from Dartmouth College, completed a postdoctoral fellowship in the Department of Psychiatry at the Yale University School of Medicine and received a B.A. in Psychology from the University of New Haven. “Jim brings extensive scientific and clinical development experience which will be valuable assets for the Trevi Board as we execute against our business plans and strategy moving forward,” said Jennifer L. Good, President and Chief Executive Officer. “I am very excited to join the Trevi Board and look forward to lending my extensive drug development experience and expertise to the Company's already deep and knowledgeable Board and strong leadership team at such an exciting time for the Company,” said Dr. Cassella. About Trevi Therapeutics, Inc. Founded in 2011, Trevi Therapeutics is headquartered in New Haven, CT. About Nalbuphine ER Investor Contact Media contact |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |